[CNP_O3] Oral Session 3

Fri. Oct 11, 2019 10:30 AM - 12:10 PM Room 8 (404)

座長：稲垣　　中（青山学院大学教育人間科学部）

+Add all to schedule

10:30 AM - 10:50 AM

[CNP-O3-1] Medication adherence and drug treatment strategies during acute exacerbation of schizophrenia

^○Kohei TANAKA, Yasuo FUJII, Ryoji MIYATA (Yamanashi Prefectural Kita Hospital.)

10:50 AM - 11:10 AM

[CNP-O3-2] Budget impact analysis of long acting injection for schizophrenia in Japan

^○Mami KIRITANI, Akihide WAKAMATSU (Janssen Pharmaceutical K.K.)

11:10 AM - 11:30 AM

[CNP-O3-3] Circadian Patterns of Hallucinatory Experiences in Patients with Schizophrenia: Potentials for Chrono-pharmacology

^○Teruki KOIZUMI^{1, 2}, Hideaki TANI^{1, 3}, Nobuhiro NAGAI^{1, 4}, Mitsuhiro TADA^{1, 8}, Kensuke NOMURA⁹, So KIRINO¹, Yuta SAITO¹, Gentarou MIURA⁵, Naoki KOMATSU¹, Kouki KAZAMA¹, Chisa OZAWA^{1, 6}, Tomomi ISHIZUKI⁷, Masaru MIMURA¹, Hiroyuki UCHIDA^{1, 3} (1. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, Japan, 3. Geriatric Mental Health Program, Centre for Addiction and Mental Health, Toronto, ON, Canada, 4. Minami-Hannou Hospital, 5. Ohizumi Hospital, 6. Ongata Hospital, 7. Takeda Hospital, 8. Department of Psychiatry, Saiseikai Central Hospital, 9. Child and adolescent psychiatry, Shimada Ryoiku Center)

11:30 AM - 11:50 AM

[CNP-O3-4] Development and clinical positioning of the drug treatment guide for schizophrenia listed in the comprehensive support and practice guide for “severe and chronic” patients

^○Ryoji MIYATA¹, Fuminari MISAWA¹, Yasuo FUJII¹, Toshihiko TAKEDA², Hiroyuki UCHIDA³ (1. Yamanashi Prefectural Kita Hospital, 2. Jikei Hospital, 3. Keio University Hospital)